Ignite Creation Date:
2025-12-24 @ 1:39 PM
Ignite Modification Date:
2026-01-24 @ 8:50 AM
Study NCT ID:
NCT04646395
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-01-30
First Post:
2020-11-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Acalabrutinib and Tafasitamab in MZL Patients
Sponsor:
International Extranodal Lymphoma Study Group (IELSG)
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IELSG49
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None